Interleukin-6 and the Skin

International Archives of Allergy and Immunology

Volumn 109, Issue 4, 1996, Pages 308-317

  Paquet, Philippe ^a   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cutaneous diseases; Cytokine; Drugs; Interleukin 6; Skin

Indexed keywords

INTERLEUKIN 6;

ENDOTHELIUM CELL; EPIDERMIS CELL; INFLAMMATORY CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN; SKIN DISEASE; SKIN FIBROBLAST;

ANIMALS; ANTIGENS, CD; BURNS; DERMATOLOGIC AGENTS; HAIR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MELANOMA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; SKIN; SKIN DISEASES; SKIN NEOPLASMS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0029945627     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237257     Document Type: Article

References (44)

1. Van Snick J: Interleukin-6: An overview. Annu Rev Immunol 1990:8:253-278.
2. Le J. Vilcek J: Interleukin 6: A multifunctional cytokine regulating immune reaction and the acute phase protein response. Lab Invest 1989: 61:588-602.
3. Kupper TS: Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 1990:86:1783-1789
4. Taga T, Flibi M, Hirata Y, Hamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gpl30. Cell 1989:58:573-581.
5. Hibi M. Murakami M. Saito M. Hirano T. Taga T. Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer. gpl30. Cell 1990:63:1149-1157.
6. Stahl N. Yancopoulos G: The alphas, betas, and kinases of cytokine receptor complexes. Cell 1993;74:587-590.
7. Stahl N, Boulton T, Farruggella T, Ip N, Davis S, Witthuhn B, Quelle F, Silvcnnoincn O, Barbieri G, Pellegrini S, Ihle J, Yancopoulos G: Association and activation of Jak-Tyk kinases by CNTF-1.IF-OSM-IL-6 beta receptor components. Science 1994:263:92-95.
8. Kimbauer R, Kak A, Schwarz T, Urbanski A, Krutmann J, Borth W, Darnm D, Shiglcy G, Ansel JC, Luger T: IFN-β2 cell differentiation factor 2, or hybridoma growth factor (IL6) is expressed and released by human epidemial cells and epidermoid carcinoma cell lines. J Immunol 1992;148:1922-1928.
9. Castells-Rodcllas A, Castell JV, Ramirez-Bosiou A, Nicolas JF, Valcucnde-Cavero F, Thivolet J: lnterleukin-6 in normal skin and psoriasis. Acta Derm Vencreol (Stockh) 1992:72:165-168.
10. Romero LI, Pincus SH: In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease. Int Arch Allergy Immunol 1992: 99:44-49.
11. Krueger JG. Krane JF. Carter DM. Gottlieb AB: Role of growth factors, cytokines and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990;94:1355-1405.
12. May LT, Ghrayeb U, Santhanam SB, Tatter Z, Stoehger DC, Helfgott N, Chiorazzi N, Gianinger G, Schgal PB: Synthesis and excretion of multiple forms of β2-interleron B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem 1988:263:7760
13. Detmar M, Tenorio S, Hettmannsperger U, Raszczak Z, Orlanos CE: Cytokine regulation of proliferation and ICAM-I expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 1992:98:147-153.
14. Kimbauer RA. Kock T. Schwarz M. Micksche M. Luger TA: Epidermal cell natural killer cell activity augmenting factor (ENKAI-) is closely related to interleukin 6 (IL6). J Invest Dermatol 1988:91:401.
15. Turkscn K. Kupper T, Deginstein L, Williams I, Fucks E: Interleukin 6: Insights to its function in skin by over expression in transgenic mice. Proc Natl Acad Sci USA 1992:89:5068-5072.
16. Snope V, Abdel-Malek Z, Kassem L, Nordlund J: Interleukins I α and 6 and tumor necrosis fac-tor-alpha arc paracrine inhibitors of human melanocytes proliferation and melanogenesis. J Invest Dermatol 1991;96:180-185.
17. Rodriguez JL, Miller CG, Gamer WL, Till GO, Guerrero P, Moore NP, Corridorc M, Normolle DP, Smith D, Remick D: Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-695.
18. Garner WL. Rodriguez JL. Miller CG. Till GO. Rees RS. Smith DJ. Rcmick DG: Acute skin injury releases neutrophil chemoattractants. Surgery 1994;116:42-48.
19. Grossman RM. Krueger J. Yourish D. Granclli-Pipemo A. Murphy DP. May LT. Küpper TS. Schgal PB. Gottlieb A: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratino-cytes. Proc Natl Acad Sei USA 1989:86:6367-6371.
20. Limat A, Hunzicker T, Waelti ER, Wasmann U, Braathen LR: Soluble factors from human hair papilla cells and dermal fibroblasts dramatically increase the clonal growth of outer root sheath cells. Arch Dennatol Res 1993:285: 205-210.
21. Ohta Y. Katayama I. Funato T, Yokozeki H. Nishiyama S. I lirano T, Kishimoto T. Nishioka K: In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: lnterleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 1991:283:351-356.
22. Neuner P, Urbanski A. Trautinger F, Muller A. Kimbauer R, Kapp A. Schopf E. Schwarz T. LugerTA: Increased IL-6 production by monocytes and keratlnoeytes in patients with psoriasis. J Invest Dermatol 1991:97:27-33.
23. Oxholm A, Oxholm P, Staberg B, Benotzen K: lnterleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment. Acta Derm Vencreol (Stockh) 1989:69:195-199.
24. Detmar M. Orfanos CE: Psoriatic kératinocytes lack intrisic hyperproliferation or altered differentiation, but display increased Susceptibility to growth stimulation by IL-6 and psoriatic serum, which is inhibited by anti-IL-6 antibody and antipsoriatic drugs (abstract). J Invest Dermatol 1992:98:516.
25. Hettmannsperger U. Detmar M. Owsianowski M. Tenorio S. Kammler HJ, Orfanos C: Cytokine-stimulated human dermal microvascutar endothelial cells produce interleukin-6 inhibition by hydrocortisone, dexamcthasone. and calcitriol. J Invest Dermatol 1992:99:531-536.
26. Prens EP, Benne K, Van Damme J, Bakku M, Brakel K, Benner R, Van Joost T: Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol 1990:95:121S-124S.
27. Lawlor F, Smith NP, Camp RDR, Bacon KB, Kolva-Black A, Greaves MW, Gearing AJH: Skin exudate levels of interleukin 6. interleukin I and other cytokines in mycosis fungoidcs. Br J Dermatol 1990:123:297-304.
28. Miles SA. Rezai AR. Salazar-Gonzalez J. Van-der Meyden M. Stevens RH. Logan DM. Mitsuyasu RT, Taga T, Hirano T, Kishimoda T, Martinez-Maza O: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990:87:4068-4072.
29. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Gzeri-Chen T, Klinenberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991:147:117-123.
30. Kodama A, Tani M, Hori K, Tozuka T, Matusi T, Ito M, Nakao S, Fryeta T, Kobayash H: Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinemia: Significant serum interlcukin-6 levels. BrJ Dermatol 1992:127:49-53.
31. Ducan MR. Berman B: Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin-6. J Invest Dermatol 1991: 97:686-692.
32. Koch AE. Kronfeld-Harrington LB. Szckanecz Z. Clio MM. Haines GK. Harlow L, Stricter RM. Kunkel SL. Massa MC. Barr WG, Jimenez SA: In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Pathobiology 1993:61:239-246.
33. Feghali CA, Bost KL, Boulware DW, Levy LS: Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured form affected skin sites of patients with scleroderma. J Rheumatol 1992;19:1207-1211.
34. Oxholm A. Oxholm P. Avnstorp C, Bendtzen K: Keratinocyte expression of interleukin 6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reaction. Acta Derm Venereol (Stockh) 1991;71:93-98.
35. Lee CE. Nculand ME. Teaford HG. Villous BE Dixon PS. Valtier S. Yeh CH. Fournier DC. Charlesworth F.N: Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992;89:1010-1020.
36. Hultner L, Szots H, Welle M, Van Sniek J, Moeller J, Dormer P: Mouse bone marrow-derived IL-3 dependent mast cells and autonomous sublines produce IL6. Immunology 1989; 67:408-413.
37. Mican JA, Arora N, Burd PR, Metcalfe DD: Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin 6. J Allergy Clin Immunol 1992;90:815-824.
38. Wlaschek M, Bolson K, Herrmann G, Schwarz A, Wilmroth F, Heinrich PC, Goerz G, Seharf-fetter-Kochanck K: UVA-induced autocrine stimulation of fibroblast-derived collagenase by IL6: A possible mechanism in dermal photodamage? J Invest Dermatol 1993;101:164-168.
39. Urbanski A. Schwarz T, Neumer P, Krutmann J, Kimbauer R, Kock A, Luger TA: Ultraviolet light induces increased circulating interleukin 6 in humans. J Invest Dermatol 1990:94:808-811.
40. Lu C. Vickers M. Kerbel R: interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 1992:89:9215-9219.
41. Lu C. Kerbel R: lnterleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 1993:120:1281-1288.
42. Berman B. Wietzerbin J, Sanceau J, Merlin G, Duncan MR: Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol 1992:98:706-712.
43. Gottlieb A, Grossman RM, Khandke L, Carter DM, Sehgal PB, Fu SM, Granelli-Pijemo A, Rivas M, Barazari L, Krueger JG: Studies of the effect of cyclosporine in psoriasis in vivo: Combined effects on activated T lymphocytes and epidermal regenerative maturation. J Invest Dermatol 1992:98:302-309.
44. Fleming TE, Mirando WS, Soohoo LF. Cooper BW, Zaitn MT, Lazarus HM, Elmets CA: An in-llammatory eruption associated with recombinant human IL-6. Br.l Dermatol 1994; 130:534-536.